Guarem in the Clinical Practice in Patients with Type 2 Diabetes Mellitus

Main Article Content

М.V. Vlasenkо,
Y.O. Kryvoviaz

Abstract

The paper presents the results of Guarem usage in 35 obese patients with impaired glucose metabolism. Guarem has a sufficient hypoglycemic effect and lipid-lowering action. The main benefit of this drug is a significant reduction in weight and body mass index in the absence of hunger. Thirty-three patients of 35 people noted the absence of increased appetite, feeling of saturation and lightness in keeping diet. Guarem is a drug of choice for the treatment of type 2 diabetic patients when diet therapy, exercise and biguanides become ineffective or poorly tolerated.

Article Details

How to Cite
Vlasenkо, М., and Y. Kryvoviaz. “Guarem in the Clinical Practice in Patients With Type 2 Diabetes Mellitus”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 8.80, Jan. 2017, pp. 24-26, doi:10.22141/2224-0721.8.80.2016.89534.
Section
To practicing Endocrinologists

References

Reutens АТ. Diabetes: individualized therapy for diabetes mellitus — just a promise? Nat. Rev. Endocrinol. 2010;6:426-427.

Pozzilli P, Leslie RD, Chan J. The A1C and ABCD of glycaemia management in type diabetes: a physician's personalized approach. Diabetes Metab. Res. Rev. 2010;26:239-244.

Prescribing information on Guarem (Ukrainian).

Diabetes mellitus, prediabetes and cardiovascular diseases. Kyiv, 2014. (Ukrainian)